IDEAYA Biosciences, Inc(NASDAQ:IDYA) 
IDEAYA Biosciences, Inc., a synthetic lethality-focused precision medicine oncology company, focuses on the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. The company's product candidate is IDE196, a protein kinase C inhibitor that is...
Website: http://www.ideayabio.com
Founded: 2015
IPO Price: $10 (May 23, 2019)
Full Time Employees: 58
CEO: Yujiro S. Hata
Sector: Healthcare
Industry: Biotechnology
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2025-04-04
P
O 15.23
H 15.61
L 14.49
C 14.71
V 2,295,057
10EMA 14.71
20EMA 14.71
60EMA 14.71
120EMA 14.71
250EMA 14.71